Skip to main content

Mental Health Parity At Last


This will extend mental health insurance benefits on a par with medical/surgical benefits to at least 30 million more people. 


And, more importantly, we have finally ushered in a 21st Century response to a set of diseases for which we still often employ 19th Century treatments – locking the door and throwing away the key.

The Mental Health Parity Act (MHPA) was passed in 2008.  Its purpose was to end insurance discrimination against people with mental illness.  

For larger group health plans, it outlawed annual and lifetime limits on mental health or substance use disorder benefits when there are no annual or lifetime limits on medical/surgical benefits. And it required that co-insurance and co-payments be substantially the same for both mental health and regular medical/surgical procedures.

As it turned out, the MHPA needed the Affordable Care Act (ACA) for it to work most effectively.  And vice-versa.

ACA extended MHPA protections to the small group and individual markets, and made mental health and substance use disorder benefits “essential benefits” that all marketplace insurers (i.e., non-grandfathered plans) had to cover.

But ACA also relied on state benchmark plans to determine how the essential mental health benefits were defined.  This opened the door to the possibility that a state might use its own definition of parity – one less strict that the federal government’s – in defining those benefits, even though the MHPA set a standard federal approach.

For years, we have wondered how the final rule would reconcile the two laws.

Good news – the final rule makes the uniform, minimum parity standard come to life.

According to the final rule, states can require better parity coverage than is required by the federal law.   

But they cannot set minimum levels of coverage that are less than those demanded by the MHPA.  And if there is a dispute about this, the rule’s preamble clearly spells out how such a dispute should be resolved: “An insurer subject to MHPAEA may be required to provide mental health or substance use disorder benefits beyond the state law minimum in order to comply with MHPAEA.” (p. 46)

Still, there are limitations to the law and the rule.

For one thing, the MHPA does not by itself mandate that all insurance products include behavioral health coverage – we need ACA for this. As the rule notes, while treatment limitations are not permitted under the MHPA, “a permanent exclusion of all benefits for a particular condition or disorder… is not a treatment limitation for purposes of this definition.”  (Sec. 54-9812-1, p.103)  

Also, it does not establish uniform co-pays for providers.  The co-pay for a behavioral health provider’s service may still be different from, say, the co-pay for a primary care provider’s service.  Instead, the co-pays are calculated based on the co-pays set for all similar medical/surgical services covered in the plan.

And in high-deductible plans certain prevention services, such as screening, may be covered at no cost, while other mental health services may either have a cost or not be covered at all (see the preamble, p. 18-19).

Finally, the rule does not entirely resolve the question of provider rate-setting – a post-MHPA issue that arose in Florida when one insurer singled out mental health providers and reduced their rates in late 2011: “Plans and issuers may consider a wide array of factors in determining provider reimbursement rates for both medical/surgical services and mental health and substance use disorder services.… The NQTL provisions require that these or other factors be applied comparably to and no more stringently than those applied with respect to medical/surgical procedures…. The Departments may provide additional guidance if questions persist with respect to provider reimbursement rates.” (p. 24)

But all in all, this is a good rule.

It extends the parity provisions that have covered most of the 130 million people in large groups under the interim rule to an additional 30 million people (p. 64), and does so at an affordable price.

This expanded coverage will cost an estimated $10.55 per person initially, and up to $1.13 billion over five years (p. 78).  It will result in an insurance premium increase of less than 1 percent in both the individual and small group markets.


The new rule will cover all plans issued, or renewed, after July 1, 2014.  That will be a good day for fairness and equity.

Note:  I started writing Our Health Policy Matters exactly three years ago, in November, 2010.  Since then, I've published at least one new column per week, without a break.  So, for the first time, I'll be taking a couple of weeks off.  I will not publish next Wednesday or the week after, but will return with new columns after Thanksgiving.  If there is breaking news between now and then (and no, I don't consider the low Obamacare enrollment numbers to be newsworthy right now, but about what should have been expected based on the enrollment numbers for the now-put-to-bed PCIP program!), I may publish something off-schedule, and catch you up after vacation if you don't visit the site between now and then.  In the meantime, if you enjoy OHPM, I encourage you to take a look at some of the older columns you might not have had time to read in the past.  And feel free to contact me directly with ideas you may have for future columns! And thanks for reading - I've been averaging 13,000 readers per month lately.  Not huge by some Web standards, but not too bad either for a once-a-week health policy effort.  I thank you, and wish you a very Happy Thanksgiving!

Paul Gionfriddo via email: gionfriddopaul@gmail.com.  Twitter: @pgionfriddo.  Facebook: www.facebook.com/paul.gionfriddo.  LinkedIn:  www.linkedin.com/in/paulgionfriddo/

Comments

Popular posts from this blog

The Missing Mental Health Element in the Ferguson Story

By now, everyone has heard the news from Ferguson, Missouri.  An unarmed 18 year old named Michael Brown was shot and killed by a police officer.  Michael Brown was black. Some of the events surrounding the shooting are in dispute.  But what isn’t in dispute is that for the past two weeks, a community has been torn apart by race – a community that until recently was best known for its proximity to St. Louis and its designation as a Playful City, USA . Picture credit: Health Affairs Media reports since the August 9 th shooting have focused almost entirely on one angle – race relations.  We’ve heard about unrest in the city, the National Guard, police in riot gear, and danger in the streets.  We’ve heard about the District Attorney’s ties to law enforcement, and concerns that a too-white Grand Jury may be racially motivated not to indict the police officer involved in the deadly shooting. But the media have been strangely silent about a different angle – this comm

Celebrating Larissa Gionfriddo Podermanski Five Years Later

My daughter Larissa died of Metastatic Breast Cancer five years ago, in May of 2018.  She had only two wishes at the end. One was that we plant a tree for her. We did - in a Middletown CT city park - and it has grown straight and tall. The other was that she not be forgotten. Larissa's family and friends took pains to reassure that she could not be forgotten. If you were fortunate enough to know Larissa, you would know why. Still, I wondered how I might celebrate her a little more now that some years have passed, while sharing some of her memorable spirit with others (some who knew her and others who did not), while reminding us why she was such an extraordinary woman. In early 2017, Larissa started a blog called Metastatically Speaking, through which she chronicled her life with MBC. Unfortunately - and through no one's fault - her blog disappeared some time after her death. So, if you search for it now, you can't find it.  However, I was fortunate enough to see and retain

Judgment Day

Ironic. I was not as nervous as you would think on April 23 rd .  Martin, my mother and I drove up to Dana Farber.  All weekend I wanted plan for Poland, Barbados and Florida, as we brainstormed ideas of what could be attainable or possible. I started to realize I looked pregnant… but that couldn’t be. When the appointment began I noticed it felt like a routine visit. Everything went smoothly, but what were we focusing on? It was this: if I did nothing the outlook for me was living three weeks to a few months longer. So, is that my only option, I wanted to know?   No, I was told we can try a low dose chemo and see how it works.   Since it is low dose, they said, it won’t do much harm, but we truly don’t know how it will work. It’s not a treatment we have used a lot at low dose and technically you are in liver failure, leaving you with limited options.   Of course, the goal would still be to get you to be stable; however, this is a blind treatment. We don’t know if this approach w